BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 16, 2003
View Archived Issues
Thyroid hormone receptor beta agonists: novel class of agents for lipoprotein disorders and obesity
Read More
First antithrombotic agent that acts by inhibiting Bruton's tyrosine kinase (BTK)
Read More
Good pharmacokinetic and safety profile reported for the new antidiabetic drug tesaglitazar
Read More
Effective termination of AF with intravenous RSD-1235
Read More
Evotec and DeveloGen enter obesity and diabetes partnership
Read More
Preclinical results reported for AZ-CINN-310 in breast cancer
Read More
Kinase inhibitors under study at Bayer
Read More
New antipsychotic dopamine D2 and/or D3 receptor ligands identified at GSK
Read More
Guanidine-based 5-HT6 receptor ligands in early development at Wyeth
Read More
Novel GSK-3 inhibitors, their preparation and use claimed by GSK scientists
Read More
Schering researchers present new inhibitors of IL-12 and IFNgamma production
Read More
Novel chemokine CCR3 receptor antagonists in GSK pipeline
Read More
BMS and QDose collaborate on inhaled insulin product development
Read More
Antisoma licenses telomerase inhibitor program
Read More
Depakote ER approved for pediatric epilepsy
Read More
European agreement covers Orthovisc distribution
Read More
Vitaxin enters phase II trials in melanoma and rheumatoid arthritis
Read More
Dosing begins in phase Ib West Nile virus study of AVI-4020
Read More
Philip Morris grant supports TNT-based lung cancer research
Read More
Bioenvision obtains clofarabine option in Japan and South East Asia
Read More
First approval for Cubicin, Cubist's once-daily antibiotic for skin and skin structure infections
Read More
Advisory committee does not recommend approval of Metvix for basal cell carcinoma
Read More
Market launch announced for Aloxi
Read More
Dihydroxypyridone monobactam PTX-2416 for resistant Gram-negative infections
Read More
Potent, orally active and rapid-acting PDE5 inhibitor discovered at Schering-Plough
Read More
Roche synthesizes peptide with potent alpha4 integrin-antagonist activity
Read More
New series of fatty acid oxidation inhibitors designed at CV Therapeutics
Read More